NanoTess Secures Federal Funding For Defence Application of Their Technology

NanoTess receives funding from Ottawa to prepare its commercialized civilian technology for defence purposes.

NanoTess has received funding from the Government of Canada to adapt its commercialized technology for defence applications. 

NanoTess has developed NanoSALV, a Health Canada approved gel-like substance that optimizes the body’s own healing mechanisms to speed up wound healing and skin health. NanoSALV is currently being used by medical professionals, surgeons and healthcare systems across Canada. 

NanoSALV, and the CTM technology inside it, could be used in defence applications like burns, lacerations, frostbite and more. 

“By driving advancements in both the civilian and military sectors, companies like NanoTess play a key role in meeting the nation’s goals for technological advantage within the Canadian Armed Forces while fundamentally improving lives globally.” - Megan Leslie, NanoTess CEO and Co-founder 

Read more about this exciting milestone here


NanoTess is in the Thin Air Labs Fund I portfolio. To learn more about this company visit their website here.